Doximity shares fall 11% as DOCS profit misses and revenue outlook trails estimates

Doximity shares fell 11.1% to $21.02 after the medical professional network reported fiscal first-quarter 2026 revenue in line with Wall Street estimates but issued softer-than-expected guidance and missed profit expectations. Revenue rose 5.1% year over year to $145.4 million. Non-GAAP earnings were 26 cents a share, 7.9% below consensus. The company guided for next-quarter revenue of $151.5 million, 1.1% below analysts’ estimates, implying 3.8% year-over-year growth. Billings totaled $185.3 million, ahead of expectations, while EBITDA also topped Wall Street forecasts. However, billings growth averaged 9.7% over the past four quarters, below revenue growth, signaling potential pressure on future sales. Analysts expect revenue to rise 7.5% over the next 12 months, down from Doximity’s 16.5% annualized growth over the past two years and its five-year compound annual growth rate of 25.5%.